Pfam Domains GO Terms
| SPRY |
| RDM |
| positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis |
| regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis |
| positive regulation of execution phase of apoptosis |
| negative regulation of cell division |
| regulation of execution phase of apoptosis |
| positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| negative regulation of G2/M transition of mitotic cell cycle |
| positive regulation of ubiquitin-dependent protein catabolic process |
| negative regulation of cell cycle G2/M phase transition |
| positive regulation of proteasomal protein catabolic process |
| positive regulation of proteolysis involved in cellular protein catabolic process |
| regulation of proteasomal ubiquitin-dependent protein catabolic process |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| positive regulation of cellular protein catabolic process |
| positive regulation of cysteine-type endopeptidase activity |
| regulation of ubiquitin-dependent protein catabolic process |
| regulation of cell division |
| positive regulation of endopeptidase activity |
| regulation of proteasomal protein catabolic process |
| positive regulation of peptidase activity |
| regulation of G2/M transition of mitotic cell cycle |
| regulation of cell cycle G2/M phase transition |
| negative regulation of mitotic cell cycle phase transition |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| regulation of proteolysis involved in cellular protein catabolic process |
| positive regulation of protein catabolic process |
| negative regulation of cell cycle phase transition |
| regulation of cysteine-type endopeptidase activity |
| regulation of cellular protein catabolic process |
| negative regulation of mitotic cell cycle |
| negative regulation of cell cycle process |
| positive regulation of proteolysis |
| positive regulation of cellular catabolic process |
| regulation of protein catabolic process |
| regulation of mitotic cell cycle phase transition |
| regulation of endopeptidase activity |
| positive regulation of catabolic process |
| regulation of peptidase activity |
| regulation of cell cycle phase transition |
| negative regulation of cell cycle |
| regulation of mitotic cell cycle |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| negative regulation of cell population proliferation |
| positive regulation of cell death |
| regulation of proteolysis |
| regulation of cell cycle process |
| positive regulation of hydrolase activity |
| regulation of cellular catabolic process |
| regulation of catabolic process |
| regulation of cell cycle |
| regulation of hydrolase activity |
| cell cycle |
| positive regulation of catalytic activity |
| regulation of apoptotic process |
| regulation of programmed cell death |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| regulation of cell death |
| positive regulation of protein metabolic process |
| positive regulation of molecular function |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution